Regenerative medicine is the discipline of medicine that focuses on the regeneration or replacement of organs, tissues, and human cells to re-established normal functionality. Regenerative medicine aims to renew or replace cells in human tissues and organs that have been damaged and are unable to function due to injury or illness. It can be attained by encouraging the body’s own cells to heal, or by treating a patient with laboratory-grown cells and tissues.
It holds potential to treat previously incurable chronic diseases and conditions, including Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, and spinal cord injuries, among others. Also, using regenerative medicine, entire organs can potentially be generated for transplantation.
How the Market Growth looks like and Industry Segmentation?
The Regenerative Medicine Market is projected to reach USD 38.7 billion by 2024, at a CAGR of 23.8% during the forecast period.
Based on type, the market is classified into cell-based immunotherapy & cell therapy products, gene therapy products, and tissue-engineered products. The cell-based immunotherapy & cell therapy products segment accounted for the largest market share in 2019 owing to increasing demand for cell-based immunotherapies, establishment of cures act by FDA to streamline the regenerative medicine approval are the major factors driving the growth of this market segment.
Based on application, the regenerative medicine market is categorized into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. In 2019, the musculoskeletal disorders segment accounted for the largest market share. The large share of this segment can mainly be attributed to the rising incidence rate of orthopedic diseases with rising geriatric population.
Browse 101 market data Tables and 29 Figures spread through 107 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579
Market Dynamics:
Opportunity: Rising Demand for Organ Transplantation;
Regenerative medicine allows medical professionals to replace broken bones and develop new organs for organ transplant. It also enables them to renew or replace cells in human tissues and organs that have been damaged and are unable to function due to injury or illness. Traditional organ transplant involves the process of replacing a failing or damaged organ in the human body with a new organ. This process involves the risk of rejection as the human body does not accept organs recognized as foreign by the body’s immune system.
The organ supply across the globe is insufficient, and the waiting lists for transplants are growing each day. According to the US Department of Health and Human Services, around 123,304 people in the US were waiting for organ transplants.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
North America anticipated to account for the largest share of the regenerative medicine market in 2019
In Global Market, The North America is expected account for the largest share globally, also grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine market by therapy, introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.
The major market players are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US).
According to the new market research report “Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025″, published by MarketsandMarkets™, the market is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.
Growth in this market is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.Browse and in-depth TOC on “Regenerative Medicine Market”131 – Tables38 – Figures165 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579The tissue-engineered products segment accounted for the largest share of the Regenerative Medicine Market, by product segment, in 2019Based on products, the market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies.
The tissue-engineered products segment accounted for the largest share in the market in 2019.
The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R of regenerative medicine products and therapies are the major factors driving the growth of this segment.Oncology segment to register the highest growth rate during the forecast periodBased on applications, the Regenerative Medicine Market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications.
In 2019, the oncology segment accounted for the highest growth rate.
This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579North America is the largest regional market for Regenerative Medicine MarketThe market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
This report aims to provide detailed insights into the NGS-based RNA-sequencing market.
It provides valuable information on the type, procedure, application, and region in the market.
Expected Revenue Growth: The NGS-based RNA-sequencing industry size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 Key Factors Driving Market Growth: Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.
The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing industry, by application, in 2018 Based on application, the NGS-Based RNA-Sequencing Market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics.
Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R spending, technological advancements in HTS, and the availability of government funding and venture capital investments.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391High Content Screening Market is segmented into following types:* High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.
High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.
* Based on product, the global market is broadly segmented into instruments, consumables, software, services, and accessories.
The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022.
Among all high content screening products, instrument segment caters to the largest share.
The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42710391Some of The Major Players In High Content Screening Market :1.
The report on the Global Cell Isolation Market provides at the close goings-on and shakeups caused by COVID-19 pandemic.
Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years.
Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology.
The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market.
Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities.
Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cell-isolation-market-6193Cell Isolation Market Competitive AnalysisThe growth of the market is influenced by the presence of factors that are stimulating the growth of the market.
